Found Review (2026)

What we verified on October 15, 2026

We read the program’s own pricing page on October 15, 2026 and recorded the figure above with its conditions. We did not enroll, so we could not see intake-only fees, the pharmacy that fills each order or any price that appears only after checkout. Other details in our May 2026 profile (care model, shipping times, lab policy) were not re-checked and are no longer shown as current.

Five checks before you enroll

1. The prescriber. Look up the clinician’s name in the NPPES NPI Registry and on your state medical or nursing board site.
2. The pharmacy. Ask which pharmacy fills the prescription and check its license with your state board of pharmacy (FDA’s BeSafeRx links to each board).
3. The 12-month total. Add the program or membership fee, the medication at your expected maintenance dose and shipping, then multiply by 12.
4. The exit terms. Read the cancellation and refund rules before the first charge.
5. The drug itself. Ask whether you will get an FDA-approved brand product or a compounded preparation. Compounded semaglutide and tirzepatide are not FDA-approved and are not generics.

How Found compares with NexLife

NexLife, our editor’s pick at 94/100 on the v4.1 methodology, publishes compounded semaglutide at $95 a month and tirzepatide at $115 a month on 12-month plans ($109 and $129 month to month), the same price at every dose with no membership, and names three 503A pharmacies on its plan pages. NexLife is not the lowest-priced program we track: Mondae lists lower month-to-month prices, and Eden Health a lower semaglutide price. Our NexLife vs Found comparison sets the two side by side.

Related reading

• Full provider directory
• NexLife review
• How to evaluate an online GLP-1 provider
• Telehealth red flags
• How we score programs (v4.1)

Scores for programs other than NexLife come from our May 2026 review (v3.0 rubric); the v4.1 re-score is pending.